Adaptive Designs in Clinical Trials
03 April 2017 - 04 April 2017
SMi’s annual conference on Adaptive Designs in Clinical Trials will return to London on 3rd & 4th April 2017. Now running for nearly a decade, this unmissable event will gather a senior audience of experts to discuss and deliberate recent innovations and successes in this exciting field of science.
As the adaptive design market continues to experience growth and advancements, this timely conference will showcase an array of topics including adaptive designs within the context of a development program, Bayesian analysis in adaptive design, biomarker-driven trials, opportunities of adaptive enrichment designs in the era of precision medicine, and much more.
HIGHLIGHTS INCLUDE:
- Hear real industry-led case studies from big pharma players at the forefront of developing strategies for adaptive designs
- Evaluate the strengths and pitfalls of leading adaptive design approaches
- Keep up to date on the latest regulatory changes and protocol for drug and device approval
- Discuss the latest trends in Bayesian statistics, biomarker driven designs and other adaptive design approaches
- Study the development of new drugs in key therapy areas such as neurodegeneration, oncology and cardiovascular diseases
- Optimise drug and device development through adaptive design approaches
FEATURED SPEAKERS INCLUDE:
- James Matcham, Head of Biometrics, Early Clinical Development, AstraZeneca
- Tom Parke, Director of Statistical Software, Berry Consulting
- Simon Kirby, Senior Director, Pfizer
- Loic Darchy, Head of Statistical Methodology Group, Sanofi R&D
- Michael Davies, Co-Founder & Chief Medical Officer, Blueberry Therapeutics Ltd
- Frank Fleischer, Principal Methodology Statistician, Boehringer-Ingelheim
- Giacomo Mordenti, Global Biometrics Director, Livanova
- Bo Huang, Director, Clinical Statistics, Pfizer
Copthorne Tara Hotel, Kensington, London UK
http://www.smi-online.co.uk/pharmaceuticals/uk/adaptive-designs
Controlled Release Delivery
03 April 2017 - 04 April 2017
SMi is delighted to announce the return of the 14th annual Controlled Release Delivery conference taking place in London, UK on the 3rd and 4th of April 2017. Aimed at drug development experts and formulation specialists, Controlled Release Delivery 2017 will reflect on the latest innovations made within controlled release.
With a carefully selected panel of industry experts, the 2017 event will address the latest regulatory updates and how to overcome challenges within the industry. Key topics that will be explored include: innovations in drug delivery, nanoparticles/nanomedicine & QbD, CNS drug delivery and therapeutic application.
Speakers include: University Of Strathclyde, Novartis Institutes for BioMedical Research, FDA, Janssen, GSK, Boehringer Ingelheim, Actelion, Merrion Pharmaceuticals and many more...
Holiday Inn Kensington Forum, London, UK
http://www.smi-online.co.uk/pharmaceuticals/uk/controlled-release?utm_medium=www.controlledreleasedelivery.com&utm_source=P-201&utm_campaign=drugdiscoverytoday
2017 Diabetes Summit
05 April 2017 - 07 April 2017
GTCbio and the advisory board would like to invite you to the 2017 Diabetes Summit to be held April 5-7, 2017 in Boston, MA. This unique event encompasses the drug discovery and partnering aspects of diabetes in two individual conferences that take place concurrently:
10th Diabetes Drug Discovery & Development Conference
I. Joint Plenary Session: Where do We Stand with Stem Cell Therapy in Diabetes?
II. Going Back to the Basics - Street Light Effect
III. Novel Therapeutic Targets & Strategies for Type I Diabetes
IV. Novel Therapeutic Targets & Strategies for Type II Diabetes
V. Translation to The Clinic: What's in the Pipeline
7th Diabetes Partnering & Deal-Making Conference
I. Current Trends and Future Projections for Investments
II. Partnering and Licensing Opportunities
III. Devices and Digital Aids in Diabetes Management
IV. Investment in Disease Modifying Therapies
V. Patient Entrepreneur Panel
VI. Biotech Showcase: Emerging Pipelines
Experts from industry and academia will discuss the bionic pancreas, bariatric surgery, the gut microbiome, obesity, and emerging therapies to target Type 1 and Type 2 diabetes in sessions and panels geared towards novel therapeutic strategies, drug discovery, and partnering with pharmaceuticals, biotech firms, and academic institutions.
We look forward to seeing you at the conference!
Hyatt Regency, Boston, MA, USA
http://www.gtcbio.com/conferences/diabetes-summit-overview
Stem Cell Summit 2017
05 April 2017 - 07 April 2017
GTCbio is proud to present the Stem Cell Summit 2017, to be held on April 5-7, 2017 in Boston, MA. GTCbio's Stem Cell Summit provides cutting-edge information on developments in all areas of stem cell research from bench to bedside, including the biology, medicine, applications, regulations, product development, and the commercialization of stem cells.
Recent developments in pre-clinical and clinical trials of stem cell therapy, regenerative medicine and tissue engineering, cancer stem cells, immunotherapy, stem cell reprogramming, regulatory policies regarding stem cell research, and manufacturing will all be discussed. Business opportunities, challenges, and potential strategies for overcoming these challenges will also be addressed. Come join us to learn what categories of companies are currently commercially viable, how they're being funded, and what kind of strategic relationships are available within the industry!
Stem Cell Summit 2017 includes two back-to-back conferences including joint plenary session
Hyatt Regency, Boston, MA, USA
https://www.gtcbio.com/conferences/stem-cell-summit-overview
Pre-Filled Syringes East Coast 2017
26 April 2017 - 27 April 2017
Building on the success of previous sell-out shows, SMi Group is delighted to announce the return of the 4th annual conference and exhibition: Pre-Filled Syringes - East Coast, taking place on April 26th – 27th 2017 in Boston, Massachusetts, USA.
With an increase in chronic diseases, high competition between market providers, and a growing demand for ready-to-administer (RTA) syringes, the dynamic pre-filled syringes market has in recent years, witnessed a huge surge in investment. However, navigating through the PFS industry in areas such as regulation, manufacturing, safety assessment and combination products, can present complex challenges to success.
Through a combination of powerful keynote addresses, topical debate and interactive workshops, Pre-Filled Syringes East Coast will once again play host to an audience of senior scientists, device manufacturers and PFS market professionals, providing a unique platform to discuss the latest innovations and developments in pre-filled syringes; as well as hone in on industry challenges and regulatory compliance.
The Colonnade Boston, Boston, MA, USA
http://www.smi-online.co.uk/pharmaceuticals/northamerica/Pre-Filled-Syringes-North-America?utm_medium=www.pfsamericas.com&utm_source=P-203&utm_campaign=drugdiscoverytoday